We identified a cluster of 9 histone deacetylase inhibitors (HDACs) which are under clinical development for cancer, and promising candidates for other diseases, including symptomatic malaria51, providing further evidence that the HDAC pathway is involved in malaria transmission52. This evidence concerns the gene HDAC9 and malaria.